Gryphon Financial Partners’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$690K Buy
1,770
+213
+14% +$90K 0.06% 191
2026
Q1
$737K Buy
1,557
+174
+13% +$87.6K 0.08% 173
2025
Q4
$646K Buy
1,383
+227
+20% +$105K 0.07% 179
2025
Q3
$493K Buy
1,156
+303
+36% +$117K 0.06% 197
2025
Q2
$327K Buy
853
+160
+23% +$57.7K 0.04% 238
2025
Q1
$239K Buy
+693
New +$223K 0.03% 255
2024
Q4
Sell
-668
Closed -$272K 266
2024
Q3
$272K Buy
+668
New +$245K 0.04% 248
2018
Q3
Sell
-179
Closed -$19K 447
2018
Q2
$19K Sell
179
-2
-1% -$202 0.01% 391
2018
Q1
$18K Sell
181
-6
-3% -$582 0.01% 406
2017
Q4
$16K Buy
+187
New +$15K 0.01% 444

Other funds holding HCA

Gryphon Financial Partners's HCA Position: Q2 2026 in Review

Gryphon Financial Partners increased its HCA Healthcare (HCA) stake by 14% in Q2 2026, buying an estimated $90K and bringing the position to 1,770 shares worth $690K. The position accounts for 0.06% of the portfolio, ranked #191.

Gryphon Financial Partners first reported a position in HCA in Q4 2017 and has held it in 10 quarters since. The position peaked at $737K in Q1 2026. 1,333 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Gryphon Financial Partners held 1,770 shares of HCA Healthcare worth $690K as of Q2 2026.
  • Gryphon Financial Partners bought 213 HCA Healthcare shares in Q2 2026, an estimated $90K.
  • HCA Healthcare made up 0.06% of Gryphon Financial Partners's portfolio in Q2 2026, its #191 holding.
  • Gryphon Financial Partners first reported a position in HCA Healthcare in Q4 2017 and has held it in 10 quarters since.
  • Gryphon Financial Partners's HCA Healthcare position peaked at $737K in Q1 2026.
  • 1,333 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Gryphon Financial Partners's 13F filing for Q2 2026, filed 5 Aug 2026.